Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chloe Ho-Yi Ma"'
Autor:
Johnny Chun-Chau Sung, Ying Liu, Kam-Chau Wu, Man-Chung Choi, Chloe Ho-Yi Ma, Jayman Lin, Emily Isabel Cheng He, David Yiu-Ming Leung, Eric Tung-Po Sze, Yusuf Khwaja Hamied, Dominic Man-Kit Lam, Keith Wai-Yeung Kwong
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1852 (2022)
The journal retracts the article “Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate” [...]
Externí odkaz:
https://doaj.org/article/425869db22aa42a68914fe320b885502
Autor:
Johnny Chun-Chau Sung, Nelson Cheuk-Yin Lai, Kam-Chau Wu, Man-Chung Choi, Chloe Ho-Yi Ma, Jayman Lin, Cheong-Nang Kuok, Wai-Leng Leong, Weng-Kei Lam, Yusuf Khwaja Hamied, Dominic Man-Kit Lam, Eric Tung-Po Sze, Keith Wai-Yeung Kwong
Publikováno v:
Vaccines, Vol 10, Iss 7, p 1014 (2022)
The coronavirus diseases 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have threatened the world for more than 2 years. Multiple vaccine candidates have been developed and approved for emer
Externí odkaz:
https://doaj.org/article/2200e5999e3148c8ad41e4361907c2e0
Autor:
Johnny Chun-Chau Sung, Ying Liu, Kam-Chau Wu, Man-Chung Choi, Chloe Ho-Yi Ma, Jayman Lin, Emily Isabel Cheng He, David Yiu-Ming Leung, Eric Tung-Po Sze, Yusuf Khwaja Hamied, Dominic Man-Kit Lam, Keith Wai-Yeung Kwong
Publikováno v:
Vaccines, Vol 10, Iss 1, p 2 (2021)
Various types of vaccines, such as mRNA, adenovirus, and inactivated virus by injection, have been developed to prevent SARS-CoV-2 infection. Although some of them have already been approved under the COVID-19 pandemic, various drawbacks, including s
Externí odkaz:
https://doaj.org/article/9cabd05020ff4300980a2ea2d37ec7a2
Autor:
Chantelle Tsoi, Ruixia Deng, Maxwell Kwok, Bin Yan, Carrie Lee, Hung Sing Li, Chloe Ho Yi Ma, Ruibang Luo, Kam Tong Leung, Godfrey Chi-Fung Chan, Larry Ming-cheung Chow, Ellen N. Poon
Publikováno v:
Frontiers in molecular biosciences. 9
Inefficient differentiation and insufficient maturation are barriers to the application of human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) for research and therapy. Great strides have been made to the former, and multiple groups have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2294cae99c297f2f59b0f6c1027159e5
https://pubmed.ncbi.nlm.nih.gov/35402504
https://pubmed.ncbi.nlm.nih.gov/35402504
Autor:
Chantelle Tsoi, Ruixia Deng, Maxwell Kwok, Bin Yan, Carrie Lee, Hung Sing Li, Chloe Ho Yi Ma, Ruibang Luo, Kam Tong Leung, Godfrey Chi-Fung Chan, Larry Ming-cheung Chow, Ellen N. Poon
Publikováno v:
Frontiers in Molecular Biosciences, Vol 9 (2022)
Inefficient differentiation and insufficient maturation are barriers to the application of human pluripotent stem cell (hPSC)-derived cardiomyocytes (CMs) for research and therapy. Great strides have been made to the former, and multiple groups have
Externí odkaz:
https://doaj.org/article/8a821034ff284df3800c7c0b2f5cb515